{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:14Z","timestamp":1793949554112,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000241","name":"Physicians' Services Inc Foundation","doi-asserted-by":"publisher","award":["20-24"],"award-info":[{"award-number":["20-24"]}],"id":[{"id":"10.13039\/501100000241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.medj.2025.100916","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:08:49Z","timestamp":1762855729000},"page":"100916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Sebastian","family":"Badulescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartej","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiya","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Brudner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Phan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Di Vincenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniqa","family":"Tabassum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Armanyous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian-Daniel","family":"Llach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Rosenblat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2025.100916_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1037\/a0028727","article-title":"Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review","volume":"139","author":"Snyder","year":"2013","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.medj.2025.100916_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s11065-020-09436-6","article-title":"Depression and Cognitive Control across the Lifespan: a Systematic Review and Meta-Analysis","volume":"30","author":"Dotson","year":"2020","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.medj.2025.100916_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2215-0366(19)30291-3","article-title":"Cognitive function following a major depressive episode: a systematic review and meta-analysis","volume":"6","author":"Semkovska","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.medj.2025.100916_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.4088\/JCP.v69n0712","article-title":"The frequency of cognitive impairment in patients with anxiety, depression, and bipolar disorder: an unaccounted source of variance in clinical trials","volume":"69","author":"Gualtieri","year":"2008","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.medj.2025.100916_bib5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/da.22063","article-title":"Cognitive deficits and functional outcomes in major depressive disorder: determinants, substrates, and treatment interventions","volume":"30","author":"McIntyre","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.medj.2025.100916_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000535665","article-title":"Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression","volume":"93","author":"Rhee","year":"2024","journal-title":"Psychother. Psychosom."},{"key":"10.1016\/j.medj.2025.100916_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11065-006-9002-x","article-title":"Executive function and the frontal lobes: a meta-analytic review","volume":"16","author":"Alvarez","year":"2006","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.medj.2025.100916_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3389\/fpsyt.2018.00539","article-title":"Executive Function and Spatial Cognition Mediate Psychosocial Dysfunction in Major Depressive Disorder","volume":"9","author":"Knight","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.medj.2025.100916_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S1092852924002293","article-title":"[The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder]","volume":"29","author":"Tamura","year":"2025","journal-title":"CNS Spectr."},{"key":"10.1016\/j.medj.2025.100916_bib10","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ijnp\/pyx070","article-title":"A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder","volume":"21","author":"Baune","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.medj.2025.100916_bib11","article-title":"The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials","volume":"19","author":"Rosenblat","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.medj.2025.100916_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s11065-018-9369-5","article-title":"A meta-analysis of the effects of antidepressants on cognitive functioning in depressed and non-depressed samples","volume":"28","author":"Prado","year":"2018","journal-title":"Neuropsychol. Rev."},{"key":"10.1016\/j.medj.2025.100916_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.neubiorev.2021.08.028","article-title":"Relationship between Central Obesity and the incidence of Cognitive Impairment and Dementia from Cohort Studies Involving 5,060,687 Participants","volume":"130","author":"Tang","year":"2021","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.medj.2025.100916_bib14","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1001\/jama.2021.4001","article-title":"Association Between Age at Diabetes Onset and Subsequent Risk of Dementia","volume":"325","author":"Barbiellini Amidei","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100916_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176898","article-title":"The impact of obesity on neuropsychological functioning in adults with and without major depressive disorder","volume":"12","author":"Restivo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.medj.2025.100916_bib16","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jad.2017.08.028","article-title":"Association of obesity with cognitive function and brain structure in patients with major depressive disorder","volume":"225","author":"Hidese","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.medj.2025.100916_bib17","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.24com15322","article-title":"The Co-occurrence of Depression and Obesity: Implications for Clinical Practice and the Discovery of Targeted and Precise Mechanistically Informed Therapeutics","volume":"85","author":"McIntyre","year":"2024","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.medj.2025.100916_bib18","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1017\/S1092852922001043","article-title":"The bidirectional association of nonalcoholic fatty liver disease with depression, bipolar disorder, and schizophrenia","volume":"28","author":"Jawad","year":"2023","journal-title":"CNS Spectr."},{"key":"10.1016\/j.medj.2025.100916_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109227","article-title":"Associations between depression and cognition, mild cognitive impairment and dementia in persons with diabetes mellitus: A systematic review and meta-analysis","volume":"185","author":"Chow","year":"2022","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.medj.2025.100916_bib20","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1186\/s13195-024-01645-y","article-title":"Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials","volume":"16","author":"Li","year":"2024","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.medj.2025.100916_bib21","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/hipo.20470","article-title":"Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats","volume":"18","author":"Stranahan","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.medj.2025.100916_bib22","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/ijo.2010.59","article-title":"Actions of exendin-4 therapy on cognitive function and hippocampal synaptic plasticity in mice fed a high-fat diet","volume":"34","author":"Gault","year":"2010","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.medj.2025.100916_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.peptides.2014.08.014","article-title":"Lixisenatide improves recognition memory and exerts neuroprotective actions in high-fat fed mice","volume":"61","author":"Lennox","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.medj.2025.100916_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejphar.2010.10.059","article-title":"Prolonged GIP receptor activation improves cognitive function, hippocampal synaptic plasticity and glucose homeostasis in high-fat fed mice","volume":"650","author":"Porter","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.medj.2025.100916_bib25","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41366-020-0535-5","article-title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: a randomized, controlled study","volume":"44","author":"Vadini","year":"2020","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.medj.2025.100916_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020734","article-title":"Activation of Glucagon-Like Peptide-1 Receptor Ameliorates Cognitive Decline in Type 2 Diabetes Mellitus Through a Metabolism-Independent Pathway","volume":"10","author":"Li","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.medj.2025.100916_bib27","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.medj.2025.100916_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2016.09.056","article-title":"Liraglutide promotes improvements in objective measures of cognitive dysfunction in individuals with mood disorders: A pilot, open-label study","volume":"207","author":"Mansur","year":"2017","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.medj.2025.100916_bib29","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/schbul\/sbae151","article-title":"Towards Enhancing Drug Development Methodology to Treat Cognitive Impairment Associated With Schizophrenia and Other Neuropsychiatric Conditions: Insights From 2 Decades of Clinical Trials","volume":"51","author":"Horan","year":"2025","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.medj.2025.100916_bib30","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/bdi.12534","article-title":"Methodological recommendations for cognition trials in bipolar disorder by the International Society for Bipolar Disorders Targeting Cognition Task Force","volume":"19","author":"Miskowiak","year":"2017","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.medj.2025.100916_bib31","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/bdi.13193","article-title":"Randomised controlled cognition trials in remitted patients with mood disorders published between 2015 and 2021: A systematic review by the International Society for Bipolar Disorders Targeting Cognition Task Force","volume":"24","author":"Miskowiak","year":"2022","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.medj.2025.100916_bib32","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2018.08.006","article-title":"Neural correlates of liraglutide effects in persons at risk for Alzheimer's disease","volume":"356","author":"Watson","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.medj.2025.100916_bib33","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2337\/dc18-2584","article-title":"Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies","volume":"42","author":"Zhang","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2025.100916_bib34","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1001\/jama.2024.7112","article-title":"Dispensing of Glucagon-Like Peptide-1 Receptor Agonists to Adolescents and Young Adults, 2020-2023","volume":"331","author":"Lee","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100916_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-75965-2","article-title":"The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy","volume":"14","author":"Kornelius","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.medj.2025.100916_bib36","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.pcd.2024.05.005","article-title":"Glucagon-like peptide receptor agonists and risk for depression","volume":"18","author":"Tagliapietra","year":"2024","journal-title":"Prim. Care Diabetes"},{"key":"10.1016\/j.medj.2025.100916_bib37","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023830","article-title":"Examining the risk of depression or self-harm associated with incretin-based therapies used to manage hyperglycaemia in patients with type 2 diabetes: a cohort study using the UK Clinical Practice Research Datalink","volume":"8","author":"Gamble","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.medj.2025.100916_bib38","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.2337\/dc20-1561","article-title":"Antidiabetes Agents and Incident Depression: A Nationwide Population-Based Study","volume":"43","author":"Kessing","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.medj.2025.100916_bib39","article-title":"Decreased Risk of Anxiety in Diabetic Patients Receiving Glucagon-like Peptide-1 Receptor Agonist: A Nationwide, Population-Based Cohort Study","volume":"13","author":"Tsai","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.medj.2025.100916_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2022.105715","article-title":"Diabetes, antidiabetic medications and risk of depression - A population-based cohort and nested case-control study","volume":"140","author":"Wium-Andersen","year":"2022","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.medj.2025.100916_bib41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.jad.2024.10.062","article-title":"Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: A replication study using reports to the World Health Organization pharmacovigilance database (VigiBase(R))","volume":"369","author":"McIntyre","year":"2025","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.medj.2025.100916_bib42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14740338.2023.2295397","article-title":"The association between glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and suicidality: reports to the Food and Drug Administration Adverse Event Reporting System (FAERS)","volume":"23","author":"McIntyre","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.medj.2025.100916_bib43","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamainternmed.2024.4369","article-title":"GLP-1 Receptor Agonist Use and Risk of Suicide Death","volume":"184","author":"Ueda","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.medj.2025.100916_bib44","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1007\/s00125-024-06243-z","article-title":"Association of glucagon-like peptide-1 receptor agonists with suicidal ideation and self-injury in individuals with diabetes and obesity: a propensity-weighted, population-based cohort study","volume":"67","author":"Hurtado","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/j.medj.2025.100916_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.13547","article-title":"Impact of treatment with GLP-1RAs on suicide attempts in adults persons with type 2 diabetes: A retrospective comparative effectiveness study based on a global TriNetX health research database","volume":"16","author":"Nassar","year":"2024","journal-title":"J. Diabetes"},{"key":"10.1016\/j.medj.2025.100916_bib46","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.23335","article-title":"GLP-1 Receptor Agonists and Suicidality-Caution Is Needed","volume":"7","author":"Salvo","year":"2024","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.medj.2025.100916_bib47","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/jamainternmed.2024.4346","article-title":"Psychiatric Safety of Semaglutide for Weight Management in People Without Known Major Psychopathology: Post Hoc Analysis of the STEP 1, 2, 3, and 5 Trials","volume":"184","author":"Wadden","year":"2024","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.medj.2025.100916_bib48","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(22)00173-8","article-title":"Suicide and self-harm","volume":"399","author":"Knipe","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100916_bib49","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(23)01127-3","article-title":"Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): a multicentre, randomised, phase 3b trial","volume":"402","author":"Aroda","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2025.100916_bib50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.14255","article-title":"Effects of oral semaglutide on energy intake, food preference, appetite, control of eating and body weight in subjects with type 2 diabetes","volume":"23","author":"Gibbons","year":"2021","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.medj.2025.100916_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/JCP.0000000000001803","article-title":"Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder","volume":"44","author":"McElroy","year":"2024","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.medj.2025.100916_bib52","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.amepre.2019.11.005","article-title":"Effect of an Intervention for Obesity and Depression on Patient-Centered Outcomes: An RCT","volume":"58","author":"Rosas","year":"2020","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.medj.2025.100916_bib53","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1016\/j.xphs.2019.04.022","article-title":"Quantifying the Value of Orally Delivered Biologic Therapies: A Cost-Effectiveness Analysis of Oral Semaglutide","volume":"108","author":"Abramson","year":"2019","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.medj.2025.100916_bib54","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.2147\/DDDT.S166765","article-title":"The development of an oral GLP-1 receptor agonist for the management of type 2 diabetes: evidence to date","volume":"13","author":"Antza","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.medj.2025.100916_bib55","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1001\/jama.2017.14752","article-title":"Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes: A Randomized Clinical Trial","volume":"318","author":"Davies","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.medj.2025.100916_bib56","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/acps.13387","article-title":"A randomised controlled trial of psychotherapy and cognitive remediation to target cognition in mood disorders","volume":"145","author":"Douglas","year":"2022","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.medj.2025.100916_bib57","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/bdi.13021","article-title":"Effect of Action-Based Cognitive Remediation on cognitive impairment in patients with remitted bipolar disorder: A randomized controlled trial","volume":"23","author":"Ott","year":"2021","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.medj.2025.100916_bib58","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2190\/T8EM-C8YH-373N-1UWD","article-title":"Assessing psychiatric impairment in primary care with the Sheehan Disability Scale","volume":"27","author":"Leon","year":"1997","journal-title":"Int. J. Psychiatry Med."},{"key":"10.1016\/j.medj.2025.100916_bib59","series-title":"Introduction to Mediation, Moderation, and Conditional Process Analysis: A Regression-Based Approach","author":"Hayes","year":"2013"},{"key":"10.1016\/j.medj.2025.100916_bib60","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3758\/BRM.40.3.879","article-title":"Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models","volume":"40","author":"Preacher","year":"2008","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.medj.2025.100916_bib61","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.cct.2003.10.016","article-title":"Assessment of blinding in clinical trials","volume":"25","author":"Bang","year":"2004","journal-title":"Control. Clin. Trials"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003435?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634025003435?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T16:18:29Z","timestamp":1767975509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634025003435"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2666634025003435"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2025.100916","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide for the treatment of cognitive dysfunction in major depressive disorder: A randomized clinical trial","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2025.100916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"100916"}}